ProfileGDS4132 / 240519_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 32% 33% 35% 30% 28% 29% 29% 32% 26% 29% 25% 25% 24% 22% 26% 25% 19% 28% 28% 21% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10180.923332
GSM201543Muscle PCOS pioglitazone 12173.261833
GSM201544Muscle PCOS pioglitazone 16189.427835
GSM201545Muscle PCOS pioglitazone 20180.105630
GSM201829Muscle PCOS pioglitazone 23172.961728
GSM201830Muscle PCOS pioglitazon 25171.621529
GSM201831Muscle PCOS pioglitazone 27169.255529
GSM201832Muscle PCOS pioglitazone 3179.353432
GSM201833Muscle PCOS pioglitazone 4157.885226
GSM201834Muscle PCOS pioglitazone 8169.768129
GSM201835Muscle PCOS after pioglitazone 10246.471325
GSM201836Muscle PCOS after pioglitazone 12249.492225
GSM201837Muscle PCOS after pioglitazone 16243.386624
GSM201838Muscle PCOS after pioglitazone 20244.03122
GSM201839Muscle PCOS after pioglitazone 23254.833226
GSM201840Muscle PCOS after pioglitazone 25256.261325
GSM201841Muscle PCOS after pioglitazone 27230.776719
GSM201842Muscle PCOS after pioglitazone 3253.6128
GSM201843Muscle PCOS after pioglitazone 4266.785828
GSM201844Muscle PCOS after pioglitazone 8242.12521